Tag: nstemi

1. There does not appear to be any difference in outcome between pre- and post-treatment administration of P2Y12 inhibitors among patients experiencing a non-ST elevation acute coronary syndrome with planned invasive intervention. 2. Prasugrel and ticagrelor showed similar outcomes when administered post-treatment. Evidence Rating Level: 1 (Excellent) Though it is well established...
1. Patients with obesity undergoing percutaneous coronary intervention are typically younger with more cardiovascular risk factors, but may be less likely to experience procedural complications, short-term and long-term adverse outcomes, with the exception of patients considered extremely obese Evidence Rating Level: 2 (Good) It has been well established that obesity is...
1. Fondaparinux had a lower risk of in-hospital and post-hospitalization bleeding events and death compared to low molecular weight heparin (LMWH) treatment. 2. There was no difference in recurrence of myocardial infarction and stroke between the two groups. Evidence Rating Level: 1 (Excellent) Study Rundown: In 2007, based on the prior OASIS-5...
Image: PD  1. Among patients diagnosed with non ST-segment elevation myocardial infarction (NSTEMI) independent of cardiac troponin levels, 26% of patients did not meet the >20% delta criteria for diagnosis.  2. NSTEMI patients not meeting the delta troponin criteria were more likely to present with primary symptoms other than chest pain...